pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
SBRT combined with PD-1 inhibitors and thoracic hyperthermia
Phase 2 · other · Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC
SBRT combined with PD-1 inhibitors and thoracic hyperthermia for Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC is a Phase 2 program (other) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code SBRT-PT
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 2
- Modality
- other
- Indication
- Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC
- Status
- active
- Trials
- 1